Benzinga's Top #PreMarket Losers

By: via Benzinga
Celladon Corp (NASDAQ: CLDN) shares fell 74.49 percent to $3.49 in pre-market trading on the failed CUPID2 trial of MYDICAR in ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.